T1	Participants 13 98	gastrointestinal cancer: the Southeastern Cancer Study Group experience, 1979 to 1983
T2	Participants 215 287	at 30 member institutions of the Southeastern Cancer Study Group (SECSG)
T3	Participants 398 412	1,087 patients
T4	Participants 628 672	Adenocarcinoma of the gastrointestinal tract
